Credits: Unsplash
A report by Swachh Bharat Mission says that 74.5 per cent of public places are equipped with toilets. Another report by the Ministry of Jal Shakti states that there are 2.23 lakh Community Sanitary Complexes built across all States and UTs under the Swachh Bharat Mission (SBM) since October 2014. Over 92 lakh toilets have been constructed since the launch of SBM Gramin (SBM (G)) in April 2020.
While toilets are there, are they accessible? This is the question one should ask. The National Family Health Survey (NFHS) focuses on 131 health indicators, but not until the NFHS 5 survey did they include the question of accessibility of toilets in the survey. This happened after the inputs from the Department of Drinking Water and Sanitation (DDWS) and the Ministry of Health & Family Welfare questioned the accessibility.
One might ask, why is the question of accessibility so important? The answer is quite simple. Access to water, sanitation and hygiene is the most basic human need and is also included under the Sustainable Development Goals by the UN.
This thought crossed my mind because back in 2021, I went on a solo trip, on a bus to Udaipur from Delhi. There, the bus made two stoppages. This was done so people could get a quick dinner and freshen up, relieve themselves and be prepared for the rest of the journey. This was a nightmare. The bus only stopped for 10 minutes. While some men used the washroom, others went to the bushes.
For the women, there were three cubicles. One of them was broken, and the other one did not have a light bulb, which meant only one was usable. There was a long queue for that cubicle, and time was short. There was no point in trying to find an isolated corner, because it was past midnight, in an unknown area.
I waited anxiously. When finally, my turn came, I saw an overused, dirty washroom. The toilet seat is in a horrible condition. I wanted to touch nothing there. But I had to pee. So, I used my mask to cover my nose from the odour, folded my pants so they did not touch the floor and squatted. It was quite a task to balance.
On my way back to Delhi, I made sure to not drink any water for over a 13-hour bus journey. I dehydrated myself so I did not have to use the washroom. When I did reach, I was severely dehydrated and was sick for three days.
I shared my experience with my friends only to realise that many women have faced the same. There are no washrooms for women.
A friend of mine told me that it is because these roads and dhabas are mainly designed to serve men. They are the ones who travel at night or are on the roads most of the time. As a result, the few women who do travel or are on the road suffer.
Well, it is true, but partially. While holding your pee for too long can lead to health risks, peeing on a dirty toilet seat cannot lead to infections unless your urethra is in contact with the bacteria present on that toilet seat. However, nobody wants to sit on a dirty toilet seat, even if you do not get an infection. A safe and hygienic toilet is a basic need.
One of the regular saleswomen, Usha, who visits my house shared her experience with me. “Being on the road constantly means I must use the dirty public washrooms. But I do not want to use them. So, sometimes I ask my regular customers to let me use their washrooms. Some say yes, and some say no. I understand they are also concerned about their safety and privacy,” she says. As a result, Usha spends most of her day not drinking enough water and holding her pee when she is at work. Due to this, she also suffered from a Urinary Tract Infection (UTI).
Her friend, Halima too faced similar problems and due to increased levels of uric acid in her body, she suffered from Hyperuricemia.
Other health risks are kidney stones and other kidney problems, headaches, dull skin, xerostomia or dry mouth, fatigue, and urinary incontinence, which means losing control over your pelvic floor muscles leading to uncontrolled leakage of urine, seizures and weakness.
Wear comfortable clothes and capris. Capri pants are comfortable and are short in length, which means this won’t touch the toilet floor when you squat or sit.
Even though you cannot get a UTI alone from sitting on a toilet seat, it is always safe to carry a toilet seat sanitiser. If nothing, it can help you get rid of the bad odour so you can use your stand and pee device inside the toilet. You can also use disposable toilet seat covers if your knees are weak, and you cannot squat. Always flush with your seat down.
Always keep disposable gloves, a portable bidet (fill it with water before use), a pocket liquid handwash, wet wipes, tissues and sanitiser handy. Do not forget to keep extra sanitary pads. It might sound a lot, but I promise that it all fits in one pouch. Use this travel-friendly pouch every time you are on the road, or using a public washroom.
However, in case we do not get these technologically advanced toilets here, you can always pack a travel-friendly toilet kit!
Credits: Canva
A federal vaccine advisory group in the United States is preparing to decide whether newborns should continue to receive the hepatitis B vaccine, which was the first shot proven to prevent cancer. The CDC committee is expected to revisit the long-standing guidance from the early 1990s, when the vaccine began to be given within the first 24 hours of life.
As per CNN, advisers to the Centers for Disease Control and Prevention will be voting on Friday to vote on whether the agency should move away from its long-held recommendation that every infant receive the hepatitis B shot shortly after birth. The information below outlines key points everyone should understand about hepatitis B and its vaccine.
Hepatitis B is a viral infection that affects the liver. Many adults are able to clear the virus after an acute infection. Some, however, go on to develop chronic hepatitis B, which increases the risk of liver cancer, liver failure and cirrhosis, or permanent scarring of the liver.
People who live with chronic hepatitis B face a much higher chance of dying early. At the ACIP meeting on Thursday, Dr. Sandra Fryhofer, who spoke on behalf of the American Medical Association, described her experience working on a hepatitis B ward during medical school, according to CNN.
She said that those were the sickest patients she had ever encountered. She explained that she has treated people with liver disease caused by hepatitis B, cirrhosis linked to the virus, and liver cancer, as well as deaths related to the infection. Infants and young children who contract hepatitis B are far more likely to develop lifelong disease, including about 90 percent of infected babies and roughly 30 percent of children between one and five years of age.
The hepatitis B virus is highly contagious. It spreads when blood, semen or other bodily fluids from a person who carries the virus enter the body of someone who is not infected.
Certain medical conditions, personal habits and other circumstances can raise the risk, such as injection drug use or sexual contact, but the virus can infect anyone. Hepatitis B can also pass from an infected mother to her baby during childbirth, whether through a vaginal delivery or a C section.
Many people living with hepatitis B show no clear symptoms, and more than half may not know they are infected. Recent CDC figures report about 2200 newly documented cases of acute hepatitis B in 2023, although the true number is estimated to be more than six times higher, closer to 14400.
The CDC also estimates that about 640000 adults in the United States have chronic hepatitis B. Worldwide, the World Health Organization reports that 254 million people are living with chronic hepatitis B, with about 1.2 million new infections each year.
There is no treatment for acute hepatitis B. Some medicines are available for chronic infection. These treatments may need to be taken for life because there is no cure.
Vaccination is the most reliable way to prevent hepatitis B. The shots offer strong protection in infancy and continue to shield individuals well into adulthood.
Most people who live with hepatitis B contracted it as babies or very young children, when their immune systems were not fully developed, according to the CDC. At present, the agency recommends that all infants receive the vaccine at birth before leaving the hospital.
Babies usually receive a three dose series. A scientific review by the Vaccine Integrity Project found that 95 percent of healthy infants develop enough immunity after the third dose. The vaccine also lowers the risk of infection by nearly 70 percent in babies born to mothers who have hepatitis B.
More than 90 per cent of people who completed the vaccine series showed signs of continued protection 30 years later, based on CDC data.
According to the Vaccine Integrity Project’s review, giving the hepatitis B shot at birth has consistently proven safe. Only mild and short-lasting reactions have been noted, such as slight swelling or redness at the injection site and low fever. There was no rise in serious life-threatening reactions linked to the vaccine.
Dr. Anthony Fiore, an infectious diseases specialist and former CDC official who worked in the hepatitis division, described it as a very safe vaccine. He said it has been studied thoroughly before and after approval. He added that the United States vaccine safety systems have looked closely at concerns about fever or other chronic problems.
He explained that none of these concerns have been confirmed. No long-term harm has been linked to the vaccine, and nothing comes close to the danger posed by chronic hepatitis B infection.
Credits: Canva
A shingles vaccination effort launched in Wales in 2013 has produced two findings that bring new optimism to dementia research. The program appears not only to lower the likelihood of mild cognitive impairment but also to slow the course of dementia in people who already have the condition. Shingles stems from the varicella zoster virus and causes a painful rash.
Around one in three people in the United States will experience shingles during their lifetime, with the risk rising sharply with age. For this reason, adults aged fifty and older in the United States are advised to receive two doses of the shingles vaccine.
The vaccine has long been known to prevent shingles with an effectiveness above ninety percent for older adults, but recent work suggests it may hold additional advantages.
Shingles, or herpes zoster, is caused by the varicella zoster virus, which is also responsible for chickenpox. It usually presents as a cluster of blistered skin on one side of the body, often forming a band across the torso. After a person recovers from chickenpox, the virus stays in the nerve cells and can reactivate years later, especially when the immune system weakens, according to Mayo Clinic.
Dementia refers to a collection of symptoms that include significant problems with memory, reasoning, and daily function. It results from damage to brain cells caused by several conditions, including Alzheimer’s disease and vascular dementia. Although dementia becomes more common with age, it is not considered a normal part of growing older, as outlined by the World Health Organization.
Growing evidence indicates that receiving the shingles vaccine may lower the chances of developing dementia. A new study, published Tuesday in the journal Cell, builds on earlier research by proposing that the vaccine might also slow existing dementia, which could reduce the risk of death related to the disease.
“We see a change in the odds of dying from dementia among people who already have the condition,” said Dr. Pascal Geldsetzer, an assistant professor of medicine at Stanford University and senior author of the new study.
“That means the vaccine may not only prevent dementia, but it might also serve as a form of treatment because we notice improvements in people already living with the disease,” he said. “This was both surprising and encouraging.” The new study follows earlier work by Geldsetzer and his team showing that shingles vaccination may help delay or prevent dementia.
In that earlier analysis, researchers reviewed health records from older adults in Wales, where a shingles vaccine program for people in their seventies began on September 1, 2013. Under the rules of the program, individuals who were seventy-nine on that date could receive the vaccine for one year, while those aged eighty or older were not included.
That cutoff allowed researchers to compare outcomes between seventy-nine-year-olds who were offered the vaccine and eighty-year-olds who were not eligible but might have chosen to be vaccinated had they been allowed.
Challenges With The Shingles Vaccine And Reducing Dementia Progression
The next task will be to understand why the shingles vaccine might influence dementia risk or progression. The answer may lie in interactions involving the nervous system or immune response. Certain viruses that affect nerve tissue have been linked in animal studies to the harmful protein accumulation seen in Alzheimer’s disease.
Future research may examine larger and more diverse groups of people, and may also explore how the newer shingles vaccine compares with the older version used in Wales in 2013, which has since been replaced.
“At least directing part of our research efforts toward these pathways might bring important progress in both prevention and treatment,” said biomedical scientist Pascal Geldsetzer from Stanford University.
Credits: iStock
Of the many medicines that we consume on a day to day basis, we are not aware of how gradually they are actually making our health worse. One medicine that is common in many households, especially in India households, as points Dr Obaidur Rahman, Ortho and Sports Surgeon is pantoprazole, popularly sold under the name PAN40, PAN Top or PAN D. These medicines are used to treat and relieve symptoms of heartburn, which is a common symptom of acid reflux and GERD.
"A patient came to me, he was an 80-year-old male. He has a habit of taking this tablet regularly, and because of that he suffered an osteoporotic fracture. This means he fell while walking and fractured," points out Dr Rahman.
Also Read: Shingles Vaccine Linked To Slower Dementia Progression, Study Finds
He says that many people, old and young, alike, have a habit of taking this pill like a multivitamin. In fact, they have substituted with pro and prebiotics and assume that it helps with digestion. However, he points out, "If you take this regularly, your gastric mucosa stops responding against proper acid production. And there is also an impairment in digestion."
He says that in clinical practice, it has been found that this common household medicine, which is often procured as over-the-counter or OTC medicine, meaning, without prescription, could cause Vitamin B12 deficiency, and magnesium deficiency.
As per a 2023 study published in the journal BioMed Research International, pantoprazole cause bone loss, which could be prevented by adding octreotide.
The study analyzed the serum levels of calcium, phosphorus, and ALP before starting the treatment, and at the end of 12 weeks of treatment on pantoprazole, significant decline in calcium levels were noticed, as compared with other groups. The study also found that octreotide significantly prevented the effect of pantoprazole on the serum levels of calcium and ALP.
The study also found that pantoprazole decreased femoral bone density and femoral BMAD. Besides this, another decrease was found in the femoral bone weight and volume as well as the trabecular volume.
Another study from 2021, published in the European Journal of Clinical Pharmacology pointed out that 12 patients had major fractures and showed changes in serum Mg2+ and Ca2+ levels over a period of 1 month as well as the animal study also showed ionic imbalance over 8-week treatment with pantoprazole. Bone density measured for the patient at the end of the 1-month treatment was found to be in the osteopenic category, together with the animal study which showed a decrease in femur bone strength for the animal treated with pantoprazole over a period of 8 weeks.
Pantoprazole contain Proton Pump Inhibitor (PPI), and prokinetic, long-term use of PPIs is associated with the risk of bone fracture. However, alternatives like Histamine H2-receptor antagonists or H2 blockers are effective alternative that do not cause bone loss, notes a 2020 study published in journal Bone, titled Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
Famotidine (Pepcid, Calmicid, Fluxid, Mylanta AR) is a potent H2 blocker used to manage acidity and heartburn. Studies show that famotidine is not thought to raise the risk of osteoporosis.
Other options: Ranitidine (Zantac - where available, as it was withdrawn in some markets due to safety concerns) and Nizatidine are other H2 blockers.
Note: Health & Me do not encourage discontinuance of any prescribed medicine by a doctor. Before making any change in your medicine schedule, please speak to your doctor/GP.
© 2024 Bennett, Coleman & Company Limited